Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $79
Barclays analyst Sarah James maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $78 to $79.
Tenet and Cigna Extend and Expand Network Access, Effective Jan. 1, 2022
Multi-year agreement provides Cigna customers with continued in-network access to Tenet providers through 2025
Tenet Healthcare Corporation (NYSE:THC) and Cigna Corporation (NYSE:CI) today announced that they have
Watching Shares Of PDS Biotechnology, Tenet Healthcare, NVent Electric; Traders Circulate TipRanks Article Titled ‘3 Monster Growth Stocks That Are Still Undervalued’
https://www.tipranks.com/news/article/3-monster-growth-stocks-that-are-still-undervalued-7/
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.
Barclays Upgrades Tenet Healthcare to Overweight, Raises Price Target to $77
Barclays analyst Steve Valiquette upgrades Tenet Healthcare (NYSE:THC) from Equal-Weight to Overweight and raises the price target from $62 to $77.
Mizuho Maintains Buy on Tenet Healthcare, Raises Price Target to $75
Mizuho analyst Ann Hynes maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $70 to $75.
Stocks That Hit 52-Week Highs On Monday
Before 10 a.m. ET on Monday, 201 companies set new 52-week highs.
Credit Suisse Maintains Outperform on Tenet Healthcare, Raises Price Target to $88
Credit Suisse analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $71 to $88.
RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $83
RBC Capital analyst Frank Morgan maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $78 to $83.